Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
TROV [NASD]
TrovaGene, Inc.
Index- P/E- EPS (ttm)-0.57 Insider Own11.67% Shs Outstand18.91M Perf Week-1.14%
Market Cap82.07M Forward P/E- EPS next Y-0.90 Insider Trans0.29% Shs Float16.70M Perf Month0.00%
Income-10.70M PEG- EPS next Q-0.26 Inst Own19.50% Short Float4.35% Perf Quarter-14.73%
Sales0.30M P/S273.56 EPS this Y21.30% Inst Trans-9.61% Short Ratio9.04 Perf Half Y23.30%
Book/sh0.66 P/B6.58 EPS next Y-23.30% ROA-35.50% Target Price9.00 Perf Year-16.54%
Cash/sh1.65 P/C2.63 EPS next 5Y- ROE-63.00% 52W Range2.97 - 7.10 Perf YTD-24.39%
Dividend- P/FCF- EPS past 5Y0.00% ROI-50.70% 52W High-38.87% Beta-0.27
Dividend %- Quick Ratio10.20 Sales past 5Y- Gross Margin- 52W Low46.13% ATR0.30
Employees25 Current Ratio10.20 Sales Q/Q30.70% Oper. Margin- RSI (14)45.52 Volatility7.15% 6.34%
OptionableYes Debt/Eq1.19 EPS Q/Q-12.00% Profit Margin- Rel Volume0.46 Prev Close4.39
ShortableYes LT Debt/Eq1.13 EarningsNov 06 AMC Payout- Avg Volume80.33K Price4.34
Recom2.00 SMA20-4.29% SMA50-3.94% SMA200-3.63% Volume36,633 Change-1.14%
Jul-10-14Initiated Maxim Group Buy $10
Nov-13-13Reiterated Aegis Capital Buy $14 → $10
Oct-01-13Reiterated Aegis Capital Buy $14
Jul-16-13Initiated Cantor Fitzgerald Buy $10
Apr-01-13Reiterated Aegis Capital Buy $12 → $14
Dec-12-12Initiated Aegis Capital Buy $12
Dec-04-14 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +5.26%
09:05AM  Trovagene Announces Presentation of Clinical Data at the 56th American Society of Hematology Annual Meeting PR Newswire
Nov-26-14 09:05AM  Trovagene to Present at 26th Annual Piper Jaffray Healthcare Conference PR Newswire -5.12%
Nov-21-14 04:35PM  TrovaGene Cancer Technology Detects KRAS Mutation Zacks
Nov-20-14 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +8.31%
09:08AM  Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients PR Newswire
Nov-15-14 01:04PM  TROVAGENE, INC. Financials EDGAR Online Financials
Nov-12-14 08:15AM  Trovagene to Present at Upcoming Healthcare Conferences PR Newswire
Nov-06-14 04:13PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:05PM  Trovagene, Inc. Announces Third Quarter 2014 Financial Results PR Newswire
04:03PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q3 2014 Trovagene Inc Earnings Release - 4:00 pm ET CCBN
Nov-05-14 02:40PM  What's in Store for TrovaGene (TROV) This Earnings Season? Zacks
Oct-29-14 08:10AM  Trovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call PR Newswire
Oct-27-14 08:10AM  Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery PR Newswire
Oct-06-14 04:30PM  Trovagene to Present at 13th Annual BIO Investor Forum PR Newswire
Oct-03-14 06:00AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online +8.14%
Oct-01-14 08:05AM  Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium PR Newswire -5.90%
Sep-29-14 08:05AM  Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer PR Newswire +5.12%
Sep-18-14 04:00PM  TROVAGENE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Sep-17-14 08:05AM  Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
Sep-15-14 07:50AM  Can The Uptrend Continue for TrovaGene (TROV)? Zacks
Sep-08-14 06:49AM  Increased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? Zacks
Sep-04-14 06:59AM  How TrovaGene (TROV) Stock Stands Out in a Strong Industry Zacks
Aug-26-14 08:24AM  Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics PR Newswire
07:07AM  TrovaGene (TROV) Jumps: Stock Rises 9.2% Zacks
Aug-25-14 08:05AM  Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. PR Newswire +9.18%
Aug-22-14 07:33AM  Can the Rally in TrovaGene (TROV) Shares Continue? Zacks
Aug-20-14 04:47PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:05AM  Trovagene Provides Update on Its Urine-Based HPV Test PR Newswire
Aug-18-14 07:00AM  TrovaGene (TROV) Worth Watching: Stock Rises 8.8% Zacks +23.33%
Aug-12-14 09:53AM  TrovaGene (TROV) Sees Hammer Chart Pattern: Time to Buy? Zacks +5.20%
08:05AM  Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
Aug-08-14 06:01AM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Aug-07-14 04:05PM  Trovagene, Inc. Announces Second Quarter 2014 Financial Results PR Newswire
04:01PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q2 2014 Trovagene Inc Earnings Release - 4:00 pm ET CCBN
Jul-30-14 08:05AM  Trovagene Schedules Release of Second Quarter 2014 Financial Results and Investor Conference Call PR Newswire +5.63%
Jul-10-14 06:09AM  Coverage initiated on TrovaGene by Maxim Group Briefing.com
Jul-01-14 04:27PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga EDGAR Online
08:05AM  Trovagene Secures $15 Million in Debt Financing From Silicon Valley Bank and Oxford Finance PR Newswire
Jun-30-14 08:07AM  Trovagene enters into strategic alliance with Lurie Cancer Center, NMDTI theflyonthewall.com
08:05AM  Trovagene Enters Into a Strategic Alliance with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute PR Newswire
Jun-16-14 08:07AM  Trovagene announces clinical collaboratoin with Dana-Farber Cancer Institute at theflyonthewall.com
08:00AM  Trovagene Announces Clinical Collaboration with Dana-Farber Cancer Institute PR Newswire
Jun-02-14 04:43PM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online +8.73%
12:45PM  Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response PR Newswire
May-28-14 04:05PM  Trovagene to Present at Jefferies 2014 Global Healthcare Conference PR Newswire
12:24PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
09:00AM  Trovagene's Precision Cancer Monitoring Technology Referenced in Multi-Disciplinary Clinical Consensus Guidelines PR Newswire
May-21-14 06:44AM  Ophthotech (OPHT) Jumps: Stock Rises 24.5% Zacks
May-20-14 11:05AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
09:24AM  TrovaGene (TROV) is Oversold: Can It Recover? Zacks
09:00AM  Trovagene Announces Publication of Data from Clinical Validation Program Using Its Precision Cancer Monitoring Platform PR Newswire
May-14-14 05:00PM  Trovagene Announces Data Presentations, Published Abstracts at Annual Meeting of American Society of Clinical Oncology PR Newswire -9.27%
May-13-14 06:01AM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
May-12-14 08:12PM  TrovaGene's (TROV) CEO Antonius Schuh on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:08PM  Trovagene reports Q1 EPS (17c), consensus (20c) at theflyonthewall.com
04:06PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Trovagene, Inc. Announces First Quarter 2014 Financial Results PR Newswire
07:07AM  Q1 2014 TrovaGene Inc Earnings Release - 4:00 pm ET CCBN
May-09-14 06:36AM  Chelsea Therapeutics International Ltd. (CHTP) Looks Strong as Stock Shoots up 31.6% Zacks
May-05-14 04:00PM  Trovagene Schedules Release of First Quarter 2014 Financial Results and Investor Conference Call PR Newswire
06:32AM  Sequenom Inc. (SQNM) in Focus: Stock Rallies 8.6% Zacks
May-02-14 06:43AM  Merrimack Pharmaceuticals, Inc. (MACK) Appears Robust as Stock Shoots up 59.2% Zacks
May-01-14 06:40AM  Strength Seen in Avanir Pharmaceuticals, Inc. (AVNR) as Stock Shoots up 45.6% Zacks
Apr-29-14 05:33AM  Strength Seen in Agenus Inc. (AGEN) as Stock Shoots Up 19.5% Zacks +15.69%
Apr-28-14 02:03AM  Tenet Healthcare (THC) Jumps: Stock Up 9.1% Zacks
02:00AM  Universal Health Services (UHS) Jumps: Stock Up 6.1% Zacks
Apr-22-14 01:52AM  Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% Zacks
Apr-17-14 06:02PM  Nasdaq stocks posting largest percentage increases AP
Apr-16-14 10:47AM  TrovaGene (TROV) Enters Oversold Territory Zacks +12.08%
Apr-14-14 10:18AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online -6.98%
Apr-08-14 04:03PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
11:08AM  Trovagene says diagnostic platform demonstrates ability to monitor mutations at theflyonthewall.com
11:00AM  Clinical Data Presented at AACR Demonstrate Ability of Trovagene's Molecular Diagnostic Platform to Non-Invasively Track Cancer Patients' Response to Therapy PR Newswire
Apr-01-14 08:00AM  Trovagene Announces Clinical Data Presentation for Its Oncogene Mutation Monitoring Platform at the American Association for Cancer Research Annual Meeting PR Newswire
Mar-31-14 06:54AM  Weakness Seen in MannKind (MNKD): Stock Falls 7.1% Zacks +5.91%
Mar-26-14 08:00AM  Genomics and Molecular Diagnostics Pioneer Charles Cantor, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
Mar-19-14 08:00AM  Trovagene and Catholic Health Initiatives Center for Translational Research Partner to Clinically Evaluate Non-Invasive Genomic Diagnostics to Improve Cancer Care PR Newswire
Mar-17-14 10:05PM  TrovaGene's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha +6.53%
04:11PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements EDGAR Online
04:01PM  TROVAGENE, INC. Files SEC form 10-K, Annual Report EDGAR Online
04:00PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire
08:00AM  Trovagene Releases Its First Oncogene Mutation Assay Using Next Generation Sequencing, Expands Its Non-Invasive Cancer Monitoring Platform PR Newswire
Mar-03-14 08:00AM  Trovagene Schedules Release of Fourth Quarter and Year End 2013 Financial Results and Investor Conference Call PR Newswire
Feb-19-14 08:10AM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
08:00AM  Dr. Rodney S. Markin Joins Trovagene's Board of Directors PR Newswire
Feb-11-14 06:02AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Feb-06-14 08:00AM  Trovagene to Present at Two Upcoming Investor Conferences PR Newswire
Feb-05-14 11:40AM  Myriad Genetics rallies after buying rival, increasing 2014 outlook at theflyonthewall.com
Jan-21-14 07:04AM  Trovagene Is Developing A New Standard Of Care To Manage Cancer, Says CEO at Seeking Alpha
Jan-13-14 09:13AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Jan-06-14 09:18AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:00AM  Trovagene and US Oncology Research Collaborate on a Prospective Study for Urine-based KRAS Testing in Patients with Metastatic Pancreatic Cancer PR Newswire
Dec-30-13 04:21PM  Trovagene: Strong Biotech 'January Effect' Candidate For 2014 at Seeking Alpha
Dec-27-13 05:59PM  Nasdaq stocks posting largest percentage increases AP +5.94%
Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. Its technology is used in the detection and monitoring of diseases in various medical disciplines, primarily the management of cancer treatment. The company's proprietary urine-based molecular diagnostic tests are used to detect cell-free DNA and RNA originating from normal and diseased cell death that can be isolated and detected from urine. Its technology is applied in various testing, such as tumor mutation detection and monitoring, infectious disease monitoring, transplantation monitoring, and prenatal genetic diagnostics. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ZANIBONI STEVECFOJun 09Buy3.956,32925,0006,329Jun 10 03:59 PM